(Press-News.org) SAN ANTONIO, Feb. 24, 2026 – Positioning The University of Texas at San Antonio as a national anchor for aging and longevity science, its Sam and Ann Barshop Institute for Longevity and Aging Studies will receive up to $38 million in federal funding for the first nationwide clinical study in healthy longevity.
The Advanced Research Projects Agency for Health (ARPA-H), an agency of the U.S. Department of Health and Human Services, announced the contract to the Barshop Institute at UT Health San Antonio, the academic health center of UT San Antonio, cementing its standing as the nation’s leading authority in longevity science. The first-of-its-kind study will evaluate the repurposing of FDA-approved medications to delay age-related health and functional decline in generally healthy middle-aged adults, ages 60 to 65.
The contract will support the Validation and Intervention Testing for Aging, Longevity and Healthspan (VITAL-H) trial, which is integrated into the ARPA-H Proactive Solutions for Prolonging Resilience (PROSPR) program. Specifically, the Barshop Institute will use the VITAL-H trial to study the medications rapamycin, dapagliflozin and semaglutide, which based on strong preclinical evidence, promising early human data and extensive post-marketing safety experience may positively affect age-related decline in quality of life and lifespan.
“PROSPR is designed to identify therapeutics that show the aging process is not an inevitable slide into disability,” said Andrew Brack, ARPA-H program manager and creator of the PROSPR program. “VITAL-H will help show whether we can preserve everyday abilities during a critical window of midlife aging.”
For the Barshop Institute, it is the culmination of decades of pioneering biomedical science, a national vote of confidence and a proven model to translate aging research into real-world clinical impact. And it is further evidence of UT San Antonio’s growing national research standing, providing a platform for the next decade of leadership in aging science.
“For decades, the Barshop Institute has helped define the biology of aging,” said Jennifer Sharpe Potter, PhD, MPH, senior executive vice president for research and innovation for UT San Antonio. “Today, that foundational science has matured into a national clinical research effort – led from San Antonio – that will shape the future of human health and longevity.”
Barshop Institute director Elena Volpi, MD, PhD, who along with her team of investigators are nationally recognized leaders in healthy longevity research, will head the new effort.
“Over the past 50 years, global life expectancy has increased substantially, yet the age of onset of age-related diseases and disabilities has remained largely unchanged,” Volpi said. “Our population is living longer but with declining function, increased disability and reduced quality of life with major implications for healthcare utilization, caregiver burden and societal costs. Despite major advances in the biology of aging, no FDA-approved interventions currently exist to delay the onset of age-related functional decline or preserve health span in otherwise healthy adults.
“This work is focused on changing that trajectory,” she said, “advancing science that can help people live not just longer lives, but healthier ones in the decades ahead.”
The PROSPR program is intended to identify biochemical and physiological markers and develop assessment tools that allow researchers to better understand and target the underlying causes of age-related disease and build interventions focused on maintaining health during aging.
The FDA-approved rapamycin, dapagliflozin and semaglutide medications all have distinct mechanisms of action, are orally administered and have favorable safety profiles at low doses, enabling long-term use in generally healthy populations.
The trial is designed to deliver evidence on whether repurposed, FDA-approved drugs can slow age-related decline in generally healthy older adults as well as provide the first large-scale validation of Intrinsic Capacity, which is the concept for healthy aging addressing a person's physical and mental capabilities. Intrinsic Capacity is evaluated by testing cognition, mobility (locomotor), psychological, vitality and sensory functions, to gauge health in aging individuals.
The VITAL-H trial will use wearable technologies to monitor the study population selected to capture a critical window in which functional decline is measurable, yet disease burden remains relatively low. Participants will be recruited from South Texas, a region with a demographic makeup that closely mirrors the projected U.S. population in the coming decades, making the results relevant to our country’s future population aging.
“By reframing aging as a modifiable functional trajectory rather than an inevitable accumulation of disease, the study establishes a scalable, regulatory-grade framework for preventive interventions that could possibly inform future clinical development and positively affect people’s lives as they age,” Volpi said.
Clinical trials targeting aging have previously focused on treatment after disease onset, are often underpowered, and rely on narrow or single-modality clinic-based outcomes that limit sensitivity, generalizability and scalability. The VITAL-H clinical trial is designed to evaluate aging interventions earlier in the life course using endpoints capable of detecting meaningful functional change within feasible timeframes.
While the award will be centered at the Barshop Institute, located in the San Antonio Medical Center, there will be multiple partner locations throughout the city.
Regional locations and partners will include the San Antonio Geriatric Research, Clinical and Research Center (GRECC); the South Texas Veterans Health Care System (STVHCS); the Texas Diabetes Institute (TDI); the West San Antonio Food Bank (SAFB); and a UT Health San Antonio mobile clinical research clinic.
For more information on the VITAL-H Trial, visit the Barshop Institute Current Clinical Trials website at: https://barshopinstitute.uthscsa.edu/clinical-trials/
This research was, in part, funded by the Advanced Research Projects Agency for Health (ARPA-H). The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the United States Government.
The Sam and Ann Barshop Institute for Longevity and Aging Studies at UT Health San Antonio is one of the world’s premier institutes dedicated to the study of age-related diseases. The Barshop Institute is the only aging-intensive research institute in the country to have five peer-reviewed designations: three National Institute on Aging (NIA)-funded centers (Nathan Shock, Claude D. Pepper, and Population Aging and Social Studies centers), a lead site of the NIA-sponsored Interventions Testing Program, and a U.S. Department of Veterans Affairs Geriatric Research, Education and Clinical Center. UT Health San Antonio is the academic health center of The University of Texas at San Antonio (UT San Antonio).
END
Barshop Institute to receive up to $38 million from ARPA-H, anchoring UT San Antonio as a national leader in aging and healthy longevity science
2026-02-25
ELSE PRESS RELEASES FROM THIS DATE:
Anion-cation synergistic additives solve the "performance triangle" problem in zinc-iodine batteries
2026-02-25
A reserach team led by Professor Huang Zhang at Harbin University of Science and Technology recently made significant progress in the research of zinc-iodine aqueous batteries. They proposed an electrolyte additive strategy based on tetramethylammonium iodide (TMAI), which, through the synergistic effect of anions (I-) and cations (TMA+), simultaneously solved three core challenges in zinc-iodine batteries: sluggish iodine reaction kinetics, polyiodide shuttle effect, and zinc dendrite growth. This research not only achieved ...
Ancient diets reveal surprising survival strategies in prehistoric Poland
2026-02-25
An international team of archaeologists and scientists has reconstructed the diets of prehistoric communities from north-central Poland, shedding new light on how people adapted to changing environments and shifting social landscapes over three millennia between the Neolithic and the Bronze Age.
The researchers analysed human remains from 60 individuals, dated between around 4100 and 1230 BC. This long timespan encompassed key periods of Central European prehistory, including the arrival of groups with steppe ancestry from the East and the first widespread use of millet in the region. Archaeological traces of these societies are often scarce: their lightly built ...
Pre-pregnancy parental overweight/obesity linked to next generation’s heightened fatty liver disease risk
2026-02-25
Pre-pregnancy parental overweight and obesity is linked to the next generation’s heightened risk of developing fatty liver disease, a potential precursor to cirrhosis and liver failure, suggests research published online in the journal Gut.
If both parents are overweight or obese before they conceive, that child’s subsequent odds of developing MASLD by the age of 24 are more than 3 times higher, most of which is influenced by cumulative excess weight (BMI) during childhood, the findings indicate.
Non-alcoholic fatty liver disease, recently renamed metabolic dysfunction associated steatotic liver disease, or MASLD ...
Obstructive sleep apnoea may cost UK + US economies billions in lost productivity
2026-02-25
Untreated obstructive sleep apnoea may be costing the UK and US economies billions of pounds/dollars in lost productivity every year, with a considerable proportion of working age adults experiencing symptoms indicative of the breathing disorder, suggests an analysis published online in the journal Thorax.
Around 1 in 5 adults in both countries may have obstructive sleep apnoea, the analysis suggests. And the time has now come to trial workplace screening in those most at risk of harm from the daytime sleepiness associated ...
Guidelines set new playbook for pediatric clinical trial reporting
2026-02-25
Researchers at The Hospital for Sick Children (SickKids), working with international collaborators and youth and family caregivers, have developed a child- and youth-centred global standard for reporting paediatric randomized controlled trials (RCTs) protocols and final reports.
Co-published today in The BMJ, JAMA Pediatrics and The Lancet Child & Adolescent Health, the SPIRIT-Children and Adolescents (SPIRIT-C) 2026 and CONSORT-Children and Adolescents (CONSORT-C) 2026 guidelines introduce new recommendations to improve ...
Adolescent cannabis use may follow the same pattern as alcohol use
2026-02-25
A new study published in the journal Addiction shows that cannabis use among Swedish adolescents appears to follow the same population-level pattern previously observed for alcohol. The findings suggest that changes in average cannabis use among young people are reflected across the entire group—from those who use infrequently to those who use frequently.
The study is based on extensive data from the Swedish Council for Information on Alcohol and Other Drugs’ (CAN) national school surveys and includes more than 250,000 students aged 15-18 years (in grade ...
Lifespan-extending treatments increase variation in age at time of death
2026-02-25
A key goal in ageing research is not just to extend life, but to ensure more people live longer and healthier lives with less variation in age-at-death; a concept known as “squaring the survival curve.” Using a recent meta-analysis, Dr Tahlia Fulton and Associate Professor Alistair Senior from the University of Sydney School of Life and Environmental Sciences re-examined how dietary restriction and two related drugs, rapamycin and metformin, affect variation in age-at-death in vertebrates.
While two of the treatments increased average lifespan, all three increased variance. This means current lifespan-extending interventions do not "square ...
From ancient myths to ‘Indo-manga’: Artists in the Global South are reframing the comic
2026-02-25
Since their so-called “Golden Age” in the 1940s, comics have often been treated as a universal visual language: stories told in panels and speech bubbles that function much the same wherever they appear.
Now, a new volume of comics studies is challenging that assumption. Comics and the Global South brings together work from Latin America, Africa, Asia and beyond to argue that comics from these regions need to be read on their own cultural terms. Doing so, the book suggests, will unsettle long-held ...
Putting some ‘muscle’ into material design
2026-02-24
By Leah Shaffer
Natural muscle fibers are made up of spring-like proteins that can contract and stretch without losing their original form, dissipate mechanical energy as heat and maintain incredible tensile strength for all sorts of physical functions. Engineers at Washington University in St. Louis have replicated these proteins using synthetic biology approaches to create a new category of biomaterials for use in medicine, textiles and agriculture.
“Many muscle proteins share similar immunoglobulin-like structures while bearing diverse amino acid sequences. These natural materials provide great ...
House fires release harmful compounds into the air
2026-02-24
Wildfires have increased in frequency and severity over the past few decades. More fires are burning at the wildland-urban interface (WUI), where homes and other buildings meet the natural landscape — but our understanding of emissions from structure fires is still growing.
New research led by the University of Colorado Boulder's Cooperative Institute for Research in Environmental Sciences (CIRES) shows that common synthetic materials used in homes, like plastics and insulation, can release harmful compounds into the air when they burn.
But synthetic materials make up only a small fraction of a home. Timber and wood ...